Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1992 Nov;67(11):1330–1337. doi: 10.1136/adc.67.11.1330

Psychological effects of sodium valproate and carbamazepine in epilepsy.

G Stores 1, P L Williams 1, E Styles 1, Z Zaiwalla 1
PMCID: PMC1793785  PMID: 1471883

Abstract

Information from standardised tests of intelligence, school attainments, attention, memory and visuomotor function, together with parent and teacher questionnaire information about various aspects of behaviour, was obtained for 63 schoolchildren with newly diagnosed epilepsy before treatment with sodium valproate or carbamazepine, and again at intervals for a total period of 12 months. The same information was collected on 47 matched controls. The children with epilepsy represented those under non-specialised paediatric care. The result showed that both drugs were effective in most cases at modest dosage without causing notable psychological effects 12 months into treatment. Modest and temporary adverse cognitive effects seen earlier in treatment could have been the result of uncontrolled seizure discharge. Improved function was the same in children with epilepsy and controls. Some psychological abnormalities in the children with epilepsy were evident before treatment suggesting early unwanted effects of the epileptic process itself.

Full text

PDF
1330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aman M. G., Werry J. S., Paxton J. W., Turbott S. H., Stewart A. W. Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication. Epilepsia. 1990 Jan-Feb;31(1):51–60. doi: 10.1111/j.1528-1157.1990.tb05360.x. [DOI] [PubMed] [Google Scholar]
  2. BAYLEY N., PINNEAU S. R. Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr. 1952 Apr;40(4):423–441. doi: 10.1016/s0022-3476(52)80205-7. [DOI] [PubMed] [Google Scholar]
  3. Bartsch O., Weschke B., Weber B. Oestrogen treatment of constitutionally tall girls with 0.1 mg/day ethinyl oestradiol. Eur J Pediatr. 1988 Jan;147(1):59–63. doi: 10.1007/BF00442613. [DOI] [PubMed] [Google Scholar]
  4. COSTA L. D., VAUGHAN H. G., Jr, LEVITA E., FARBER N. Purdue Pegboard as a predictor of the presence and laterality of cerebral lesions. J Consult Psychol. 1963 Apr;27:133–137. doi: 10.1037/h0040737. [DOI] [PubMed] [Google Scholar]
  5. Forsythe I., Butler R., Berg I., McGuire R. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol. 1991 Jun;33(6):524–534. doi: 10.1111/j.1469-8749.1991.tb14917.x. [DOI] [PubMed] [Google Scholar]
  6. Gale A., Lynn R. A developmental study of attention. Br J Educ Psychol. 1972 Nov;42(3):260–266. doi: 10.1111/j.2044-8279.1972.tb00719.x. [DOI] [PubMed] [Google Scholar]
  7. Gillham R. A., Williams N., Wiedmann K. D., Butler E., Larkin J. G., Brodie M. J. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res. 1990 Dec;7(3):219–225. doi: 10.1016/0920-1211(90)90018-q. [DOI] [PubMed] [Google Scholar]
  8. Hagerman R. J., Jackson C., Amiri K., Silverman A. C., O'Connor R., Sobesky W. Girls with fragile X syndrome: physical and neurocognitive status and outcome. Pediatrics. 1992 Mar;89(3):395–400. [PubMed] [Google Scholar]
  9. Herranz J. L., Arteaga R., Armijo J. A. Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients. Epilepsia. 1982 Apr;23(2):203–214. doi: 10.1111/j.1528-1157.1982.tb05068.x. [DOI] [PubMed] [Google Scholar]
  10. John G., Schellong G. Ostrogentherapie hochwüchsiger Mädchen. Ergebnisse bei 71 Patientinnen. Monatsschr Kinderheilkd. 1980 Aug;128(8):545–550. [PubMed] [Google Scholar]
  11. Lenko H. L. Prediction of adult height with various methods in Finnish children. Acta Paediatr Scand. 1979 Jan;68(1):85–92. doi: 10.1111/j.1651-2227.1979.tb04965.x. [DOI] [PubMed] [Google Scholar]
  12. MIRSKY A. F., VANBUREN J. M. ON THE NATURE OF THE "ABSENCE" IN CENTRENCEPHALIC EPILEPSY: A STUDY OF SOME BEHAVIORAL, ELECTROENCEPHALOGRAPHIC AND AUTONOMIC FACTORS. Electroencephalogr Clin Neurophysiol. 1965 Mar;18:334–348. doi: 10.1016/0013-4694(65)90053-2. [DOI] [PubMed] [Google Scholar]
  13. Prader A., Largo R. H., Molinari L., Issler C. Physical growth of Swiss children from birth to 20 years of age. First Zurich longitudinal study of growth and development. Helv Paediatr Acta Suppl. 1989 Jun;52:1–125. [PubMed] [Google Scholar]
  14. Reeser H. M., Heremans G. F., van Gelderen H. H. Reduction of adult height in tall girls. Eur J Pediatr. 1979 Sep;132(1):37–41. doi: 10.1007/BF00443202. [DOI] [PubMed] [Google Scholar]
  15. Roche A. F., Davila G. H., Eyman S. L. A comparison between Greulich-Pyle and Tanner-Whitehouse assessments of skeletal maturity. Radiology. 1971 Feb;98(2):273–280. doi: 10.1148/98.2.273. [DOI] [PubMed] [Google Scholar]
  16. Roche A. F., Eyman S. L., Davila G. H. Skeletal age prediction. J Pediatr. 1971 Jun;78(6):997–1003. doi: 10.1016/s0022-3476(71)80430-4. [DOI] [PubMed] [Google Scholar]
  17. Schain R. J., Ward J. W., Guthrie D. Carbamazepine as an anticonvulsant in children. Neurology. 1977 May;27(5):476–480. doi: 10.1212/wnl.27.5.476. [DOI] [PubMed] [Google Scholar]
  18. Schoen E. J., Solomon I. L., Warner O., Wingerd J. Estrogen treatment of tall girls. Am J Dis Child. 1973 Jan;125(1):71–74. doi: 10.1001/archpedi.1973.04160010045010. [DOI] [PubMed] [Google Scholar]
  19. Silverstein F. S., Parrish M. A., Johnston M. V. Adverse behavioral reactions in children treated with carbamazepine (Tegretol). J Pediatr. 1982 Nov;101(5):785–787. doi: 10.1016/s0022-3476(82)80321-1. [DOI] [PubMed] [Google Scholar]
  20. Sorgo W., Scholler K., Heinze F., Heinze E., Teller W. M. Critical analysis of height reduction in oestrogen-treated tall girls. Eur J Pediatr. 1984 Sep;142(4):260–265. doi: 10.1007/BF00540248. [DOI] [PubMed] [Google Scholar]
  21. Stores G. Studies of attention and seizure disorders. Dev Med Child Neurol. 1973 Jun;15(3):376–382. doi: 10.1111/j.1469-8749.1973.tb04898.x. [DOI] [PubMed] [Google Scholar]
  22. Tanner J. M., Landt K. W., Cameron N., Carter B. S., Patel J. Prediction of adult height from height and bone age in childhood. A new system of equations (TW Mark II) based on a sample including very tall and very short children. Arch Dis Child. 1983 Oct;58(10):767–776. doi: 10.1136/adc.58.10.767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tanner J. M., Whitehouse R. H., Marshall W. A., Carter B. S. Prediction of adult height from height, bone age, and occurrence of menarche, at ages 4 to 16 with allowance for midparent height. Arch Dis Child. 1975 Jan;50(1):14–26. doi: 10.1136/adc.50.1.14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Treisman A. M., Gelade G. A feature-integration theory of attention. Cogn Psychol. 1980 Jan;12(1):97–136. doi: 10.1016/0010-0285(80)90005-5. [DOI] [PubMed] [Google Scholar]
  25. Trimble M. R., Cull C. Children of school age: the influence of antiepileptic drugs on behavior and intellect. Epilepsia. 1988;29 (Suppl 3):S15–S19. doi: 10.1111/j.1528-1157.1988.tb05805.x. [DOI] [PubMed] [Google Scholar]
  26. Zachmann M., Ferrandez A., Můrset G., Prader A. Estrogen treatment of excessively tall girls. Helv Paediatr Acta. 1975 May;30(1):11–30. [PubMed] [Google Scholar]
  27. Zachmann M., Nessi P. Theoretical growth evaluation (TGE). A computerized screening system for growth disorders. Clin Pediatr (Phila) 1984 Nov;23(11):609–616. doi: 10.1177/000992288402301102. [DOI] [PubMed] [Google Scholar]
  28. Zachmann M., Sobradillo B., Frank M., Frisch H., Prader A. Bayley-Pinneau, Roche-Wainer-Thissen, and Tanner height predictions in normal children and in patients with various pathologic conditions. J Pediatr. 1978 Nov;93(5):749–755. doi: 10.1016/s0022-3476(78)81071-3. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES